top of page
logo

NAD+: What Does the Research Actually Show?

NAD+ research explained in plain language, including cellular energy metabolism, aging research, NAD+ precursors, human clinical studies, safety questions, and what researchers still don't know.


Nicotinamide adenine dinucleotide, commonly called NAD+, has become one of the most discussed molecules in longevity and wellness research.


It is involved in fundamental processes throughout the body, including cellular energy metabolism and signaling pathways involved in DNA repair, stress responses and metabolism.


Interest in NAD+ has grown partly because researchers have observed changes in NAD+ metabolism during aging and disease.


That has led to an important research question:

Can increasing NAD+ availability actually improve human health?

The answer is more complicated than many advertisements and social-media claims suggest.


Preclinical research has produced intriguing findings, while human trials have demonstrated that several NAD+ precursors can increase NAD+-related metabolites.


However, evidence that these changes consistently produce meaningful improvements in human health remains limited and mixed.


What Is NAD+?


NAD+ stands for nicotinamide adenine dinucleotide.


It is a molecule found throughout living cells and plays an essential role in metabolism.


One of its best-known functions is acting as a redox cofactor, helping cells transfer electrons during metabolic reactions.


NAD+ also participates in signaling processes involving enzymes such as sirtuins and PARPs.


Because these systems are involved in energy metabolism, cellular stress responses and DNA-related processes, researchers have become interested in whether changes in NAD+ availability could influence aging and disease.


Importantly, NAD+ is not simply an "energy supplement."


It is part of a much larger and highly regulated biological system.


Why Are Researchers Interested in NAD+?


NAD+ research has expanded dramatically because of its connection to several fundamental biological processes.


Researchers have investigated relationships between NAD+ metabolism and:

  • Cellular energy production

  • Mitochondrial function

  • DNA repair

  • Cellular stress responses

  • Metabolism

  • Inflammation

  • Aging

  • Muscle function

  • Cardiovascular biology

  • Neurodegenerative disease


Preclinical studies have produced particularly interesting results.


However, translating those findings into humans has proven much more difficult.


A 2025 review in Nature Metabolism concluded that although preclinical studies support NAD+ precursor supplementation as a promising strategy, human clinical trials have

generally shown limited efficacy.


Does NAD+ Decline With Age?


This is one of the most interesting questions in the field.


Some research has reported age-related reductions in NAD+ levels in certain human tissues.


However, the evidence is not consistent across every tissue or measurement method.


A 2026 study examining NAD+ levels in whole blood across seven human cohorts found that whole-blood NAD+ levels remained relatively stable with age. The researchers also found that NAD+ levels changed following nicotinamide riboside supplementation.


That finding is important because it demonstrates that whole-blood NAD+ may not be a reliable universal marker of biological aging.


Different tissues can have different NAD+ concentrations and metabolic requirements.


Therefore, measuring NAD+ in blood does not necessarily tell researchers what is happening inside every tissue.


How Do Researchers Try to Increase NAD+?


There are several approaches being investigated.


These include direct NAD+ administration and compounds that serve as NAD+ precursors.


Commonly studied precursors include:

  • Nicotinamide riboside (NR)

  • Nicotinamide mononucleotide (NMN)

  • Nicotinamide

  • Nicotinic acid

NR and NMN have received particularly strong research interest.


The theory is relatively straightforward:

Provide the body with compounds that can enter NAD+ biosynthetic pathways and potentially increase NAD+ availability.


But biology is rarely that simple.


Absorption, tissue distribution, metabolism, cellular transport and individual differences can all influence the final result.


What Does Human Research Show?


Human research has established that some NAD+ precursors can increase NAD+-related measurements.


For example, a randomized placebo-controlled study involving healthy middle-aged and older adults found that six weeks of nicotinamide riboside supplementation increased blood cellular NAD+ concentrations and was well tolerated during the study period.


Another randomized study involving 120 healthy adults found that an NR-containing formulation increased whole-blood NAD+ concentrations over eight weeks.


These studies demonstrate an important point:

NAD+ precursors can produce measurable biological changes in humans.

But increasing a biomarker is not automatically the same as improving health.


That distinction is central to understanding the current NAD+ literature.


Does Increasing NAD+ Improve Metabolic Health?


This is where the evidence becomes less convincing.


NMN has been investigated in multiple randomized controlled trials involving adults.

A meta-analysis of eight NMN trials involving 342 participants found that short-term NMN supplementation did not significantly improve fasting glucose, fasting insulin, HbA1c, insulin resistance or lipid profiles.


A newer 2026 systematic review and meta-analysis included 15 trials evaluating short-term oral NMN supplementation and similarly found no clear broad metabolic benefit, although some preliminary signals involving diastolic blood pressure and insulin resistance were identified. The authors emphasized that larger and longer studies are needed.


So the current evidence does not support the idea that raising NAD+ automatically produces broad metabolic improvements.


What About Aging and Longevity?


This is probably the area where NAD+ research receives the most attention.


Animal studies have produced intriguing findings involving metabolism, mitochondrial function, inflammation and other aging-related pathways.


But humans are not laboratory mice.


A 2025 Nature Metabolism review concluded that the human evidence remains limited and that effects observed in animal models cannot simply be extrapolated to people.


A 2026 Nature Medicine editorial similarly noted that clinical evidence for anti-aging interventions remains sparse and that human trials involving NAD+ supplementation have not yet demonstrated strong disease-modifying effects.


That does not mean NAD+ research is unimportant.


It means the field has not yet answered the bigger question:

Does increasing NAD+ meaningfully extend healthy human lifespan or prevent age-related disease?


That remains an open research question.


NAD+ vs. NAD+ Precursors


Another important distinction is the difference between NAD+ itself and compounds that are used to increase NAD+ availability.


Research involving NR or NMN should not automatically be interpreted as evidence that administering NAD+ itself produces the same effects.


The compounds have different properties, metabolism and routes through which they may influence NAD+ biology.


A 2026 systematic review identified 33 human intervention studies examining NAD-related compounds, but found that clinical outcomes were heterogeneous and often null or specific to individual endpoints. It also noted that no eligible outcomes trials evaluated intravenous or intramuscular NAD+ itself for anti-aging or wellness indications.


This is an important distinction when evaluating claims about NAD+ therapies.


What About NAD+ and Cellular Energy?


NAD+ plays a central role in cellular metabolism.


It participates in reactions that allow cells to extract energy from nutrients.


Because mitochondria depend heavily on NAD+/NADH chemistry, researchers have investigated whether maintaining NAD+ availability could influence mitochondrial function.


This has generated substantial preclinical interest.


However, demonstrating that NAD+ participates in energy metabolism does not prove that additional NAD+ will make a healthy person feel more energetic.


That requires controlled human studies measuring meaningful outcomes.


What About Physical Performance?


NAD+ and its precursors have also been investigated in relation to muscle and physical performance.


Some NMN trials have reported changes in measures of physical performance, while others have not.


A systematic review of randomized controlled trials involving NMN identified 10 studies involving 437 participants. The authors found that the evidence was still limited by relatively small sample sizes and short follow-up periods.


This is another example where the research is interesting but not yet definitive.


What About Safety?


Safety is an important part of NAD+ research.


Human studies of NAD+ precursors such as NR and NMN have generally reported favorable short-term tolerability.


For example, the 2026 NMN meta-analysis found no significant increase in overall adverse events, serious adverse events or withdrawals related to adverse events in the included short-term trials.


However, these studies generally involved relatively short treatment periods.


That means short-term tolerability should not automatically be interpreted as proof of long-term safety.


Researchers still need better information about:

  • Long-term exposure

  • Different routes of administration

  • Higher exposures

  • Individual differences

  • Effects in people with chronic diseases

  • Tissue-specific NAD+ changes

  • Potential effects of altering NAD+ metabolism over extended periods


What Researchers Still Don't Know


Despite the enormous interest in NAD+ biology, several major questions remain.


Long-term effects


Researchers need larger studies with longer follow-up to determine whether sustained NAD+ elevation produces meaningful benefits or unexpected consequences.


Which tissues matter most?


NAD+ metabolism differs between tissues.


Increasing NAD+ in blood does not necessarily mean that the same increase occurs in muscle, brain, liver or other tissues.


Who benefits?


Different people may respond differently to NAD+ precursors.


Age, metabolism, health status, diet, genetics and the microbiome may all influence responses.


What is the optimal approach?


Researchers have not established one universally optimal NAD+ precursor, dose, route or schedule for improving human health.


Does increasing NAD+ improve longevity?


This remains unanswered.


Increasing a biological marker is not enough to demonstrate increased lifespan or healthspan.


What are the meaningful clinical endpoints?


Future research needs to determine whether NAD+ interventions improve outcomes that actually matter to people—not simply laboratory biomarkers.


Common NAD+ Claims vs. What the Evidence Shows


Because NAD+ has become a major wellness topic, it can be difficult to separate research from marketing.


Claim: "NAD+ reverses aging."


What the evidence shows:NAD+ biology is strongly connected to aging research, particularly in experimental models. However, human evidence has not established that NAD+ supplementation reverses biological aging.


Claim: "NAD+ supplementation dramatically increases energy."

What the evidence shows:NAD+ is essential to cellular energy metabolism, but this does not establish that supplemental NAD+ produces a clinically meaningful increase in energy in healthy humans.


Claim: "Raising NAD+ improves metabolism."

What the evidence shows:Some human studies demonstrate biochemical changes, but randomized NMN trials have generally not demonstrated broad improvements in glucose or lipid metabolism.


Claim: "NAD+ is proven to extend human lifespan."

What the evidence shows:There is currently insufficient human evidence to establish that NAD+ supplementation extends lifespan.


Claim: "More NAD+ is always better."

What the evidence shows:NAD+ metabolism is highly regulated and involves multiple cellular pathways. Researchers are still investigating the consequences of manipulating this system over the long term.


Why NAD+ Research Still Matters


The fact that the evidence is incomplete does not make NAD+ research unimportant.

Quite the opposite.


NAD+ sits at the intersection of several fundamental biological systems.


Researchers are continuing to investigate whether manipulating NAD+ metabolism could eventually have meaningful applications in areas such as aging, metabolic disease, cardiovascular health, neurological disease and mitochondrial biology.


The next stage of the field will require larger, better-designed human studies.


The most useful research will focus less on whether NAD+ levels increase and more on whether that increase produces reproducible improvements in meaningful clinical outcomes.


The Bottom Line


NAD+ is a fundamental molecule involved in cellular metabolism and signaling.

Research has demonstrated that NAD+ biology is closely connected to many processes involved in cellular function and aging.


Human studies have also demonstrated that certain NAD+ precursors, particularly NR and NMN, can increase NAD+-related measurements in humans.


But the bigger claims are not yet established.


Current human evidence does not demonstrate that increasing NAD+ universally reverses aging, dramatically improves metabolism or extends human lifespan.


The most accurate description of the field is:

NAD+ is an important and actively studied area of biological research, with promising mechanistic and preclinical findings, measurable effects in human studies, but still-unresolved questions about long-term clinical effectiveness and health outcomes.

That is precisely why continued research matters.


Sources & Further Reading


Explore the Research

Interested in exploring the compounds discussed in this article?

Visit Latitude 40 Aminos to explore our research-compound catalog and available product information.

 
 
 

Comments

bottom of page